Evidence map›Paper›PMID 39996135›Full record

ArticleTherapeutic advances in gastroenterology2025

Body mass index changes after fecal microbiota transplantation for recurrent

Kanika Sehgal, Parul Berry, Janice Cho, George Saffouri, Ross A Dierkhising, Eric Battaglioli, Purna C Kashyap, Darrell Pardi, Sahil Khanna

Abstract read
In one paragraph

Article in Therapeutic advances in gastroenterology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors.

Kanika SehgalDivision of Gastroenterology and Hepatology, Mayo Clinic, Rochester, MN, USA.ORCID https://orcid.org/0000-0002-0186-3583
Parul BerryDivision of Gastroenterology and Hepatology, Mayo Clinic, Rochester, MN, USA.ORCID https://orcid.org/0000-0002-0860-4496
Janice ChoDepartment of Gastroenterology, Northwest Permanente Physicians and Surgeons, Portland, OR, USA.
George SaffouriDivision of Gastroenterology and Hepatology, University of California Riverside School of Medicine, Riverside, CA, USA.
Ross A DierkhisingDivision of Clinical Trials and Biostatistics, Department of Quantitative Health Sciences, Mayo Clinic, Rochester, MN, USA.
Eric BattaglioliDepartment of Biology, Emory College of Arts and Science, Emory University, Atlanta, GA, USA.
Purna C KashyapDivision of Gastroenterology and Hepatology, Mayo Clinic, Rochester, MN, USA.
Darrell PardiDivision of Gastroenterology and Hepatology, Mayo Clinic, Rochester, MN, USA.
Sahil KhannaDivision of Gastroenterology and Hepatology, Mayo Clinic, 200 1st Street SW, Rochester, MN 55905, USA.ORCID https://orcid.org/0000-0002-7619-8338

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Background: Fecal microbiota transplantation (FMT) is a successful therapy for Objectives: We investigated changes in the recipient's BMI after FMT in relation to the donor's BMI. Design: We conducted a retrospective cohort study involving patients who underwent FMT for recurrent CDI at Mayo Clinic between 2012 and 2019. Methods: We analyzed demographic and donor data for patients undergoing FMT at Mayo Clinic (2012-2019). Recipient BMI (pre- and post-FMT) and donor BMI were extracted from medical records. Mixed-effects linear regression was used to evaluate the impact of donor BMI, donor BMI category, recipient baseline BMI, time before and after FMT, and interactions between these variables on overall BMI change and BMI change per month. Kaplan-Meier curves were used to assess BMI changes (⩾5 units) based on the last recorded post-FMT BMI. Results: We analyzed data from 401 patients with recorded BMI measurements before and after FMT. The median age of the recipients at the time of FMT was 59.1 years (interquartile range (IQR): 40.5-70.1 years), with 61.6% being female. The median BMI for recipients prior to FMT was 26.7 kg/m² (IQR: 22.7-31.6 kg/m²), while the median BMI of the donors was 24.5 kg/m Conclusion: The lack of impact of donor BMI on BMI changes post-FMT suggests that these changes are more dependent on the recipient's metabolic profile. Prospective, controlled trials are required to analyze these results more comprehensively.

Indexed as

body mass indexClostridioides difficilefecal microbiota transplant

Identifiers

PMID39996135
PMCPMC11848891

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.